E3 PreliminaryPreliminaryPEM unclearEditorialPeer-reviewedReviewed
Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G protein-coupled receptors?
Staines, Donald · Medical hypotheses · 2005 · DOI
Quick Summary
This paper proposes that ME/CFS might involve problems with special proteins on cell surfaces called G protein-coupled receptors (GPCRs), which normally help cells respond to stress and manage energy. The author suggests that certain immune molecules and genetic variations could damage these receptors, disrupting the cell's ability to produce energy and causing fatigue. This is a theoretical explanation rather than a proof based on patient data.
Why It Matters
Understanding GPCR dysfunction could potentially explain why ME/CFS patients experience persistent fatigue and problems generating cellular energy. If this mechanism is correct, it might open new avenues for developing treatments targeting these receptor pathways or correcting faulty signaling.
Observed Findings
- No empirical findings are presented; this is a theoretical mechanistic proposal
- The paper does not report data from patient cohorts or experimental models
- No direct measurements of GPCR function, cAMP levels, or ATP metabolism in ME/CFS are provided
Inferred Conclusions
- G protein-coupled receptor dysfunction may be a common mechanistic feature linking fatigue in ME/CFS, Gulf War syndrome, and possibly SIDS
- Autoimmune activation of vasoactive neuropeptides and associated proteins may impair GPCR signaling and disrupt cellular energy metabolism
- Overexpression of inhibitory Gi proteins or null variant receptors could account for major disruptions in adenylate cyclase signaling and ATP/cAMP pathways
Remaining Questions
- Do ME/CFS patients actually show abnormal GPCR function or altered cAMP/ATP metabolism compared to healthy controls?
- What specific autoimmune mechanisms cause GPCR desensitization or null variant overexpression in these conditions?
- Could GPCR-targeted therapies improve energy metabolism and fatigue in ME/CFS patients?
- How do heat shock proteins and CpG DNA fragments mechanistically alter GPCR signaling?
What This Study Does Not Prove
This study does not provide experimental evidence that GPCR dysfunction actually occurs in ME/CFS patients, nor does it prove that the proposed mechanism causes fatigue. It is a theoretical hypothesis without clinical data, patient samples, or mechanistic validation. The connections between vasoactive neuropeptides, heat shock proteins, and GPCR damage remain speculative.
Tags
Symptom:Fatigue
Biomarker:AutoantibodiesBlood Biomarker
Method Flag:Exploratory Only
Metadata
- DOI
- 10.1016/j.mehy.2005.02.013
- PMID
- 15893112
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.